Cargando…

Luminescence complementation technology for the identification of MYC:TRRAP inhibitors

Mechanism-based targeted therapies have exhibited remarkable success in treating otherwise untreatable or unresectable cancers. Novel targeted therapies that correct dysregulated transcriptional programs in cancer are an unmet medical need. The transcription factor MYC is the most frequently amplifi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feris, Edmond J., Hinds, John W., Cole, Michael D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522838/ https://www.ncbi.nlm.nih.gov/pubmed/34676047 http://dx.doi.org/10.18632/oncotarget.28078

Ejemplares similares

Formation of a structurally-stable conformation by the intrinsically disordered MYC:TRRAP complex
por: Feris, Edmond J., et al.
Publicado: (2019)

S146L in MYC is a context-dependent activating substitution in cancer development
por: Hinds, John W., et al.
Publicado: (2022)

The Diarylheptanoid Curcumin Induces MYC Inhibition and Cross-Links This Oncoprotein to the Coactivator TRRAP
por: Mödlhammer, Alexander, et al.
Publicado: (2021)

Involvement of the zebrafish trrap gene in craniofacial development
por: Suzuki, Taichi, et al.
Publicado: (2021)

TRRAP is a central regulator of human multiciliated cell formation
por: Wang, Zhao, et al.
Publicado: (2018)

TRRAP stimulates the tumorigenic potential of ovarian cancer stem cells
por: Kang, Kyung Taek, et al.
Publicado: (2018)

TRRAP-mediated acetylation on Sp1 regulates adult neurogenesis
por: Yin, Bo-Kun, et al.
Publicado: (2022)

The adenoviral E1A N-terminal domain represses MYC transcription in human cancer cells by targeting both p300 and TRRAP and inhibiting MYC promoter acetylation of H3K18 and H4K16
por: Zhao, Ling-Jun, et al.
Publicado: (2016)

Beyond HAT Adaptor: TRRAP Liaisons with Sp1-Mediated Transcription
por: Yin, Bo-Kun, et al.
Publicado: (2021)

Analysis of TRRAP as a Potential Molecular Marker and Therapeutic Target for Breast Cancer
por: Wang, Ji, et al.
Publicado: (2016)

The TRRAP transcription cofactor represses interferon-stimulated genes in colorectal cancer cells
por: Detilleux, Dylane, et al.
Publicado: (2022)

HAT cofactor TRRAP modulates microtubule dynamics via SP1 signaling to prevent neurodegeneration
por: Tapias, Alicia, et al.
Publicado: (2021)

Lipid droplet screen in human hepatocytes identifies TRRAP as a regulator of cellular triglyceride metabolism
por: Abbey, Deepti, et al.
Publicado: (2021)

TRRAP Enhances Cancer Stem Cell Characteristics by Regulating NANOG Protein Stability in Colon Cancer Cells
por: Kang, Kyung-Taek, et al.
Publicado: (2023)

Mutational analysis of the GNA11, MMP27, FGD1, TRRAP and GRM3 genes in thyroid cancer
por: MURUGAN, AVANIYAPURAM KANNAN, et al.
Publicado: (2013)

HSF1 phosphorylation establishes an active chromatin state via the TRRAP–TIP60 complex and promotes tumorigenesis
por: Fujimoto, Mitsuaki, et al.
Publicado: (2022)

MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy
por: Holien, Toril, et al.
Publicado: (2015)

Interaction of transcription factor FoxO3 with histone acetyltransferase complex subunit TRRAP modulates gene expression and apoptosis
por: Fusi, Lorenza, et al.
Publicado: (2022)

The Action Mechanism of the Myc Inhibitor Termed Omomyc May Give Clues on How to Target Myc for Cancer Therapy
por: Savino, Mauro, et al.
Publicado: (2011)

CircTRRAP Knockdown Has Cardioprotective Function in Cardiomyocytes via the Signal Regulation of miR-370-3p/PAWR Axis
por: Zhang, Yuan, et al.
Publicado: (2022)

The chromatin remodeling factors EP300 and TRRAP are novel SMYD3 interactors involved in the emerging ‘nonmutational epigenetic reprogramming’ cancer hallmark
por: Fasano, Candida, et al.
Publicado: (2023)

The role of lanthanide luminescence in advancing technology
por: Tessitore, Gabriella, et al.
Publicado: (2023)

Strategically targeting MYC in cancer
por: Posternak, Valeriya, et al.
Publicado: (2016)

Optimization of Luminescent Assay for Screening of Cyclin-Dependent Kinase 2 Inhibitors
por: Suthar, M. P., et al.
Publicado: (2010)

Complement receptor is an inhibitor of the complement cascade
Publicado: (1981)

A Luminescence-Based System for Identification of Genetically Encodable Inhibitors of Protein Aggregation
por: Nelson, Travis J., et al.
Publicado: (2020)

De novo variant of TRRAP in a patient with very early onset psychosis in the context of non-verbal learning disability and obsessive-compulsive disorder: a case report
por: Mavros, Chrystal F., et al.
Publicado: (2018)

Luminescence- and Fluorescence-Based Complementation Assays to Screen for GPCR Oligomerization: Current State of the Art
por: Wouters, Elise, et al.
Publicado: (2019)

MYC inhibitors in multiple myeloma
por: Martínez-Martín, Sandra, et al.
Publicado: (2021)

Nanotag luminescent fingerprint anti-counterfeiting technology
por: Johansen, Stefan, et al.
Publicado: (2012)

M. leprae components induce nerve damage by complement activation: identification of lipoarabinomannan as the dominant complement activator
por: Bahia El Idrissi, Nawal, et al.
Publicado: (2015)

Small Molecule Microarrays Enable the Identification of a Selective, Quadruplex-Binding Inhibitor of MYC Expression
por: Felsenstein, Kenneth M., et al.
Publicado: (2015)

Complement 1 Inhibitor Is a Regulator of the Alternative Complement Pathway
por: Jiang, Haixiang, et al.
Publicado: (2001)

ROCK inhibitor reduces Myc-induced apoptosis and mediates immortalization of human keratinocytes
por: Dakic, Aleksandra, et al.
Publicado: (2016)

Computational analysis of complement inhibitor compstatin using molecular dynamics
por: Devaurs, Didier, et al.
Publicado: (2020)

Irradiated Shellfish: Identification by Photostimulated Luminescence
por: Campagna, Maria Concetta, et al.
Publicado: (2014)

Identification of Novel Cdc7 Kinase Inhibitors as Anti-Cancer Agents that Target the Interaction with Dbf4 by the Fragment Complementation and Drug Repositioning Approach
por: Cheng, An Ning, et al.
Publicado: (2018)

The case of complement inhibitors
por: Noris, Marina
Publicado: (2021)

Correction: MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy
por: Holien, Toril, et al.
Publicado: (2018)

Excitation Energy‐Transfer Processes in the Sensitization Luminescence of Europium in a Highly Luminescent Complex
por: Huang, Yan‐Jie, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_72cmsls6hgsvm1gdsmj6t1urh7